JOINT FILING AGREEMENT
EXHIBIT 99.1
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Skye Bioscience, Inc. shall be filed on behalf of each of the undersigned and that this Joint Filing Agreement shall be filed as an exhibit to such Schedule 13D.
Dated: December 19, 2024
5AM Ventures VII, L.P. By: its General Partner By: /s/ Xxxxxx X. Xxxxxx
Name: Xxxxxx X. Xxxxxx Title: Managing Member |
By: /s/ Xxxxxx X. Xxxxxx
Name: Xxxxxx X. Xxxxxx Title: Managing Member |
5AM Ventures II, L.P. By: 5AM Partners II, LLC its General Partner By: /s/ Xxxxxx X. Xxxxxx
Name: Xxxxxx X. Xxxxxx Title: Managing Member 5AM Co-Investors II, L.P. By: 5AM Partners II, LLC its General Partner By: /s/ Xxxxxx X. Xxxxxx
Name: Xxxxxx X. Xxxxxx Title: Managing Member | 5AM Partners II, LLC By: /s/ Xxxxxx X. Xxxxxx
Name: Xxxxxx X. Xxxxxx Title: Managing Member |
/s/ Xxxxxx X. Xxxxxx
Xxxxxx X. Xxxxxx /s/ Xx. Xxxx Xxxxxx Xx. Xxxx Xxxxxx /s/ Xx. Xxxx X. Xxxxxxx Xx. Xxxx X. Xxxxxxx /s/ Xx. Xxxxx X. Xxxxxxxx
Xx. Xxxxx X. Xxxxxxxx |